sentence_eng_Latn: Study 316 was a randomised, double-blind trial of posaconazole oral suspension (200 mg three times a day) versus fluconazole capsules (400 mg once daily) in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease (GVHD).
sentence_ayr_Latn: 316 yatiqäwix sum sum uñakipatawa, waljkut yant’ata uka lakatuq posaconazole ukt’añataki (200 mg urunx kimskuti) yaqhaxa fluconazole kasulanakraki (400 mg urunx mäkuti) uka alogeniconakana kunaysatix uka tayka hematopoyéticas silulanakax turkataki uka utjir usunakaruxa (GVHD).